Our data demonstrated that the growth inhibitory effect of naftopidil is independent of the androgen sensitivity and AR dependency of the cells or the α1-adrenaline receptor subtype expression in the LNCaP sublines, suggesting that naftopidil induces G1 cell-cycle arrest in various cancer cell types. Here, AR is linked to cancer.